Comparison of Original and Generic Enoxaparin for Treatment of Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention

被引：1
|
作者：
Vichairuangthum, Kitigon [1 ]
Chotenoparatpat, Paiboon [1 ]
机构：
[1] Vajira Hosp, Bangkok, Thailand
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期
关键词：
D O I：
10.1016/j.jacc.2014.02.174
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCTAPA-145
引用
收藏
页码：S41 / S42
页数：2
相关论文
共 50 条
  • [1] Young coronary artery disease in patients undergoing percutaneous coronary intervention
    Zuhdi, A. S.
    Mariapun, Jeevitha
    Hairi, Noran Naqiah Mohd
    Ahmad, Wan Azman Wan
    Abidin, Imran Zainal
    Undok, Abdul Wahab
    Ismail, Muhammad Dzafir
    Sim, Kui-hian
    [J]. ANNALS OF SAUDI MEDICINE, 2013, 33 (06) : 572 - 578
  • [2] Enoxaparin for anticoagulation in patients undergoing percutaneous coronary intervention
    James, Stefan
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [3] Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients
    Yasuda, Kaoru
    Kasuga, Hirotake
    Aoyama, Toru
    Takahashi, Hiroshi
    Toriyama, Takanobu
    Kawade, Yasumasa
    Iwashima, Shigejiro
    Yamada, Shigeki
    Kawahara, Hirohisa
    Maruyama, Shoichi
    Yuzawa, Yukio
    Ishii, Hideki
    Murohara, Toyoaki
    Matsuo, Seiichi
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (08): : 2322 - 2332
  • [4] The obesity paradox of mortality in patients with coronary artery disease undergoing percutaneous coronary intervention
    Lin, Gen-Min
    Li, Yi-Hwei
    Jaiteh, Lamin E. S.
    Han, Chih-Lu
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (02) : 597 - 597
  • [5] Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
    Gu, Jun
    Yin, Zhao-fang
    Xu, Zuo-jun
    Fan, Yu-qi
    Wang, Chang-qian
    Zhang, Jun-feng
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [6] Hyperuricemia and severity of coronary artery disease in patients undergoing selective percutaneous coronary intervention
    刘勇
    陈丽玲
    谭宁
    周颖玲
    何鹏程
    谢年谨
    罗建方
    陈津
    陈纪言
    [J]. South China Journal of Cardiology, 2010, 11 (04) : 195 - 202
  • [7] Is fondaparinux safer than enoxaparin for patients undergoing percutaneous coronary intervention?
    Antman, Elliott M.
    [J]. NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2008, 5 (04): : 184 - 185
  • [8] Is fondaparinux safer than enoxaparin for patients undergoing percutaneous coronary intervention?
    Elliott M Antman
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2008, 5 : 184 - 185
  • [9] Residual inflammatory status in patients with stable coronary artery disease undergoing percutaneous coronary intervention
    Kalkman, Deborah
    Aquino, Melissa
    Baber, Usman
    Guedeney, Paul
    Sorrentino, Sabato
    Vogel, Birgit
    Claessen, Bimmer
    Giustino, Gennaro
    Sweeny, Joseph
    Kovacic, Jason
    Vijay, Pooja
    Barman, Nitin
    Kini, Annapoorna
    Sharma, Samin
    Dangas, George
    Mehran, Roxana
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B342 - B342
  • [10] Pre-existing depression in patients with coronary artery disease undergoing percutaneous coronary intervention
    Park, Jangho
    Park, Sangwoo
    Kim, Yong-Giun
    Ann, Soe Hee
    Park, Hyun Woo
    Suh, Jon
    Roh, Jae-Hyung
    Cho, Young-Rak
    Han, Seungbong
    Park, Gyung-Min
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
12345